CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

IRP; INT1L1; Secreted Growth Factor; Int-1-related protein

  • CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Packages (Simulation)
  • CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Packages (Simulation)
  • CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Results demonstration
  • SCL820Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

This assay has high sensitivity and excellent specificity for detection of Wingless Type MMTV Integration Site Family, Member 2 (WNT2).
No significant cross-reactivity or interference between Wingless Type MMTV Integration Site Family, Member 2 (WNT2) and analogues was observed.

Recovery of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

Matrices listed below were spiked with certain level of recombinant Wingless Type MMTV Integration Site Family, Member 2 (WNT2) and the recovery rates were calculated by comparing the measured value to the expected amount of Wingless Type MMTV Integration Site Family, Member 2 (WNT2) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-98 92
EDTA plasma(n=5) 79-89 82
heparin plasma(n=5) 95-102 99

Precision of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Wingless Type MMTV Integration Site Family, Member 2 (WNT2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Wingless Type MMTV Integration Site Family, Member 2 (WNT2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Wingless Type MMTV Integration Site Family, Member 2 (WNT2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-103% 79-89% 80-88% 95-105%
EDTA plasma(n=5) 81-103% 78-91% 97-105% 97-105%
heparin plasma(n=5) 90-102% 78-96% 93-101% 94-101%

Stability of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2)

The microplate provided in this kit has been pre-coated with an antibody specific to Wingless Type MMTV Integration Site Family, Member 2 (WNT2). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Wingless Type MMTV Integration Site Family, Member 2 (WNT2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Wingless Type MMTV Integration Site Family, Member 2 (WNT2) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPL820Hu01 Recombinant Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Positive Control; Immunogen; SDS-PAGE; WB.
PAL820Hu01 Polyclonal Antibody to Wingless Type MMTV Integration Site Family, Member 2 (WNT2) WB; IHC; ICC; IP.
MAL820Hu21 Monoclonal Antibody to Wingless Type MMTV Integration Site Family, Member 2 (WNT2) WB; IHC; ICC; IP.
SEL820Hu ELISA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Enzyme-linked immunosorbent assay for Antigen Detection.
SCL820Hu CLIA Kit for Wingless Type MMTV Integration Site Family, Member 2 (WNT2) Chemiluminescent immunoassay for Antigen Detection.
GUESTBOOK